Evidence map›Paper›PMID 36906215›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2023

Spurious Electrolyte and Acid-Base Disorders in the Patient With Cancer: A Review.

Raad Chowdhury, Anna-Eve Turcotte, Helbert Rondon-Berrios, Biruh T Workeneh

Abstract readReview
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raad ChowdhuryRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Anna-Eve TurcotteDepartment of Nephrology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Helbert Rondon-BerriosRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Biruh T WorkenehDepartment of Nephrology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: btworkeneh@mdanderson.org.

Funding

Urea for chronic hyponatremia: a pilot studyR21DK122023 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RONDON BERRIOS, HELBERT, WEISBORD, STEVEN · 2020 to 2021
$430k
NIDDK NIH HHS R21 DK122023
6 · The paper itself

Abstract

Electrolyte and acid-base disorders are frequently encountered in patients with malignancy, either due to cancer itself or as a complication of its therapy. However, spurious electrolyte disorders can complicate the interpretation and management of these patients. Several electrolytes can be artifactually increased or decreased such that the serum electrolyte values do not correspond to their actual systemic levels, potentially resulting in extensive diagnostic investigations and therapeutic interventions. Examples of spurious derangements include pseudohyponatremia, pseudohypokalemia, pseudohyperkalemia, pseudohypophosphatemia, pseudohyperphosphatemia, and artifactual acid-base abnormalities. Correctly interpreting these artifactual laboratory abnormalities is imperative for avoiding unnecessary and potentially harmful interventions in cancer patients. The factors influencing these spurious results also must be recognized, along with the steps to minimize them. We present a narrative review of commonly reported pseudo electrolyte disorders and describe strategies to exclude erroneous interpretations of these laboratory values and avoid pitfalls. Awareness and recognition of spurious electrolyte and acid-base disorders can prevent unnecessary and harmful treatments.

Indexed as

Acid-Base ImbalanceHyponatremiaNeoplasmsWater-Electrolyte ImbalanceElectrolytesHumansElectrolytesPseudohypercalcemiapseudohyperkalemiapseudohypocalcemiapseudohyponatremiaspurious anion gap

Identifiers

PMID36906215
PMCPMC10491742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.